
Discovery of EBI-907: A highly potent and orally active B-RafV600E inhibitor for the treatment of melanoma and associated cancers
Keywords: B-RafV600E; Kinase; Pyrazolo[3,4-c]isoquinoline; Scaffold hopping; Cancer